Bajaj Healthcare Ltd vs Kimia Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Bajaj Healthcare Ltd is ₹ 335.2 as of 06 May 15:30 . The P/E Ratio of Bajaj Healthcare Ltd changed from 7.8 on March 2021 to 53.7 on March 2025 . This represents a CAGR of 47.09% over 5 yearsThe P/E Ratio of Kimia Biosciences Ltd changed from 35.1 on March 2021 to 20.9 on March 2025 . This represents a CAGR of -9.85% over 5 years The Market Cap of Bajaj Healthcare Ltd changed from ₹ 650.77 crore on March 2021 to ₹ 2121 crore on March 2025 . This represents a CAGR of 26.66% over 5 yearsThe Market Cap of Kimia Biosciences Ltd changed from ₹ 179.55 crore on March 2021 to ₹ 201.13 crore on March 2025 . This represents a CAGR of 2.30% over 5 years The revenue of Bajaj Healthcare Ltd for the Dec '25 is ₹ 162.87 crore as compare to the Sep '25 revenue of ₹ 149.57 crore. This represent the growth of 8.89% The revenue of Kimia Biosciences Ltd for the Dec '25 is ₹ 30.2 crore as compare to the Sep '25 revenue of ₹ 33.67 crore. This represent the decline of -10.31% The ebitda of Bajaj Healthcare Ltd for the Dec '25 is ₹ 31.9 crore as compare to the Sep '25 ebitda of ₹ 27.26 crore. This represent the growth of 17.02% The ebitda of Kimia Biosciences Ltd for the Dec '25 is ₹ 6.65 crore as compare to the Sep '25 ebitda of ₹ 2.19 crore. This represent the growth of 203.65% The net profit of Bajaj Healthcare Ltd changed from ₹ 7.13 crore to ₹ 15.67 crore over 7 quarters. This represents a CAGR of 56.83% The net profit of Kimia Biosciences Ltd changed from ₹ 1.44 crore to ₹ 5.44 crore over 7 quarters. This represents a CAGR of 113.72% The Dividend Payout of Bajaj Healthcare Ltd changed from 4.57 % on March 2021 to 7.99 % on March 2025 . This represents a CAGR of 11.82% over 5 yearsThe Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bajaj Healthcare Ltd

Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers.
The Company is engaged in the manufacturing and exporting of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals. Company commenced its operations in 1993 with a single unit at Tarapur.
It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities.
In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility.

About Kimia Biosciences Ltd

Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal.
The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
It came out with a public issue in Feb.'95 to part-finance the project.
Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking.

FAQs for the comparison of Bajaj Healthcare Ltd and Kimia Biosciences Ltd

Which company has a larger market capitalization, Bajaj Healthcare Ltd or Kimia Biosciences Ltd?

Market cap of Bajaj Healthcare Ltd is 1,128 Cr while Market cap of Kimia Biosciences Ltd is 171 Cr

What are the key factors driving the stock performance of Bajaj Healthcare Ltd and Kimia Biosciences Ltd?

The stock performance of Bajaj Healthcare Ltd and Kimia Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bajaj Healthcare Ltd and Kimia Biosciences Ltd?

As of May 6, 2026, the Bajaj Healthcare Ltd stock price is INR ₹335.2. On the other hand, Kimia Biosciences Ltd stock price is INR ₹36.3.

How do dividend payouts of Bajaj Healthcare Ltd and Kimia Biosciences Ltd compare?

To compare the dividend payouts of Bajaj Healthcare Ltd and Kimia Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.